Clinical profiles of 10 cases of ovarian malignant mixed mullerian tumor.
- Author:
Su Ho LEE
1
;
Chul Jung KIM
;
Sun Joo LEE
;
Jeong Won LEE
;
Chang Soo PARK
;
Byoung Gie KIM
;
Je Ho LEE
;
Geung Hwan AHN
;
Young Soo SON
;
Duk Soo BAE
Author Information
1. Department of Obstetrics and Gynecology, Samsung Medical Center Sungkyunkwan University School of Medicine, Seoul, Korea.
- Publication Type:Original Article
- Keywords:
Malignant mixed mullerian tumor;
Ovary
- MeSH:
Drug Therapy;
Female;
Ovary;
Prognosis;
Radiotherapy;
Survival Rate
- From:Korean Journal of Obstetrics and Gynecology
2004;47(10):1894-1898
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Malignant mixed mullerian tumors (MMMT) of the ovary are rare, constituting less than 1% of all primary ovarian tumors. Histologically, tumors include malignant epithelial and sarcomatous elements. MMMT of the ovary is a highly aggressive and rapidly progressive tumor with a poor long-term prognosis. The survival rate is very low inspite of surgery, chemotherapy and radiotherapy. The prognostic factors and optimal treatments for this tumor are still controversial because of its rarity. We experienced ten cases of malignant mixed mullerian tumors of the ovary and report our experiences with a brief review of literature.
